Key Details

  • A meeting of the Board of Directors is scheduled for Thursday, August 06, 2026
  • The primary agenda is to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter ended June 30, 2026
  • The trading window for dealing in company shares has been closed for all Designated Persons and their immediate relatives since July 01, 2026
  • The trading window will remain closed until 48 hours after the declaration of the Financial Results
  • This closure is in accordance with the company's code of conduct framed under SEBI (Prohibition of Insider Trading) Regulations, 2015

Authentication

The document is digitally signed by Sunu Manuel Abey, Company Secretary & Compliance Officer, on July 27, 2026 at 17:36:04 IST.

Additional Information

The intimation is also available on the company's website at https://www.hcgoncology.com/